Soley Therapeutics combines AI with molecular and cellular response detection for developing new efficacious drugs.
Drug Discovery📍 South San Francisco, CAFounded 2020
Current Valuation
$700M
as of 2024-Q3
PRIVATE
Soley Therapeutics combines AI with molecular and cellular response detection for developing new efficacious drugs.
Company Profile
Founded
2020
HQ
South San Francisco, CA
Employees
39
Total Raised
$290.03M
Last Round
Series C — $200M (Sep 2024)
IPO Status
private
Fundraising Status
Series C · $200M · 1y 11mo ago
privateTotal raised $290.03M
Secondary Market
Implied price / share
$21
Last round price / share
$23.14
vs last round
-9.2%
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series C
$200M
Sep 2024
—
$700M
Health CareBiotechnologyTherapeutics
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2024-Q3. Refreshed quarterly.